The 1918 Flu Pandemic and Its Aftermath
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Avian Influenza “Bird Flu”
AVIAN FLU CONCERNS ESCALATE WORLDWIDE Louise Shimmel Avian influenza (“bird flu” as it is sometimes called in the press) is making its way into the news almost daily and causing worry among global health authorities, including the Centers for Disease Control and Prevention (CDC), World Health Organization (WHO), and the National Institute of Allergy and Infectious Diseases (NIAID). Avian influenzas are not new; they come in many types with widely varying levels of disease-causing capability. Definition: Influenza type A viruses, which include human and avian flu viruses, are categorized by H and N components, which denote specific types of proteins on their surface. The H component governs the ability of the virus to bind to and enter cells, which become virus-making factories. The N component governs the release of the newly made viruses from the animal host cell." [Reuters alertnet, 16 Nov 2005, edited.] There are 16 different HA subtypes and 9 different NA in type A influenza viruses. "There are only three known A subtypes of human flu viruses (H1N1, H1N2, and H3N2). When discussing “bird flu” we are talking about the influenza A subtypes chiefly found in birds. They do not usually infect humans, even though we know they can. [Fact Sheet, Avian Influenza, William T. Ferrier, DVM - prepared for falconers.] The virus making headlines is a specific subtype-H5N1-but there is more than one form of H5N1, specifically high- and low-pathogenic strains. The high-pathogenic form of H5N1 is the one in Asia that is causing global concern. There has been a low-pathogenic form of H5N1 found in migrating wild birds in Canada this fall, which is no cause for alarm. -
Influenza Vaccine Directive
FAQS: INFLUENZA VACCINE DIRECTIVE FLU VACCINE UPDATES: Flu shots are now required for all staff working in healthcare settings in Alameda County and Berkeley, as recently ordered in a joint mandate by public health officers for Alameda County. This new mandate notes that with the flu season overlapping the COVID-19 pandemic, the risk is higher for health systems to be overwhelmed by patients with critical respiratory illness. Although there is no vaccine yet for COVID-19, the flu shot remains a safe and effective way to minimize the impacts of flu season and thousands of related doctor and hospital visits. Under Alameda County’s new order, all workers in healthcare settings must receive a flu vaccine to help protect themselves, teammates, patients and the wider community. Within our organization, all employees who work in Alameda County and have direct patient contact, must receive a flu shot no later than December 3, 2020. The new mandate specifies that you may only decline a flu shot if you provide a signed certification from your primary care provider stating that you have a medical condition that makes it unsafe to receive the flu vaccine. Masking is not an acceptable alternative to receiving the flu shot. If you haven’t yet received your flu shot, and you work in an Epic Care location within Alameda County, you must receive a flu vaccine on or before December 3, 2020. Flu vaccines are available at your local pharmacy, your doctor’s office, or Epic Care (while supplies last). If you are unable to obtain a flu vaccine through Epic Care, and you instead receive it from a different pharmacy or doctor’s office, the out of pocket cost of the vaccine will be reimbursed to you with a valid receipt for payment. -
Epidemics and Pandemics in Victoria: Historical Perspectives
Epidemics and pandemics in Victoria: Historical perspectives Research Paper No. 1, May 2020 Ben Huf & Holly Mclean Research & Inquiries Unit Parliamentary Library & Information Service Department of Parliamentary Services Parliament of Victoria Acknowledgments The authors would like to thank Annie Wright, Caley Otter, Debra Reeves, Michael Mamouney, Terry Aquino and Sandra Beks for their help in the preparation of this paper. Cover image: Hospital Beds in Great Hall During Influenza Pandemic, Melbourne Exhibition Building, Carlton, Victoria, circa 1919, unknown photographer; Source: Museums Victoria. ISSN 2204-4752 (Print) 2204-4760 (Online) Research Paper: No. 1, May 2020 © 2020 Parliamentary Library & Information Service, Parliament of Victoria Research Papers produced by the Parliamentary Library & Information Service, Department of Parliamentary Services, Parliament of Victoria are released under a Creative Commons 3.0 Attribution-NonCommercial- NoDerivs licence. By using this Creative Commons licence, you are free to share - to copy, distribute and transmit the work under the following conditions: . Attribution - You must attribute the work in the manner specified by the author or licensor (but not in any way that suggests that they endorse you or your use of the work). Non-Commercial - You may not use this work for commercial purposes without our permission. No Derivative Works - You may not alter, transform, or build upon this work without our permission. The Creative Commons licence only applies to publications produced by the -
Novel H1N1 Influenza Updated Key Points June 11, 2009 • On
Novel H1N1 Influenza Updated Key Points June 11, 2009 • On June 11, 2009, the World Health Organization (WHO) raised the worldwide pandemic alert level to Phase 6. • Designation of this phase indicates that a global pandemic is underway. • There are now community level outbreaks ongoing in other parts of the world. • State and international borders don’t matter at this point. The bottom line is that this new virus is among us all. • While U.S. influenza surveillance systems indicate that overall flu activity is decreasing in the United States, novel H1N1 outbreaks are ongoing in different parts of the U.S., in some cases with intense activity. • In the United States, this virus has been spreading efficiently from person-to-person since April and, as we have been saying for some time, we do expect that we will see more cases, more hospitalizations and more deaths from this virus. • Because there is already widespread novel H1N1 disease in the United States, the WHO Phase 6 declaration does not change what the United States is currently doing to keep people healthy and protected from the virus. • Thus there is no change to CDC’s recommendations for individuals and communities. • WHO’s decision to raise the pandemic alert level to Phase 6 is a reflection of epidemiological changes in other parts of the world and not a reflection of any change in the novel H1N1 virus or associated illness. • At this time, most of the people who have become ill with novel H1N1 in the United States have not become seriously ill and have recovered without hospitalization. -
Chapter 19 Influenza
Chapter 19: Influenza October 2020 19 Influenza Influenza The disease Influenza is an acute viral infection of the respiratory tract. There are three types of influenza virus: A, B and C. Influenza A and influenza B are responsible for most clinical illness. Influenza is highly infectious with a usual incubation period of one to three days. The disease is characterised by the sudden onset of fever, chills, headache, myalgia and extreme fatigue. Other common symptoms include a dry cough, sore throat and stuffy nose. For otherwise healthy individuals, influenza is an unpleasant but usually self-limiting disease with recovery usually within two to seven days. The illness may be complicated by (and may present as) bronchitis, secondary bacterial pneumonia or, in children, otitis media. Influenza can be complicated more unusually by meningitis, encephalitis or meningoencephalitis. The risk of serious illness from influenza is higher amongst children under six months of age (Poehling et al., 2006; Ampofo et al., 2006; Coffin et al., 2007; Zhou et al, 2012), older people (Thompson et al., 2003 and 2004; Zhou et al, 2012) and those with underlying health conditions such as respiratory or cardiac disease, chronic neurological conditions, or immunosuppression and pregnant women (Neuzil et al., 1998; O’Brien et al., 2004; Nicoll et al., 2008 and Pebody et al., 2010). Influenza during pregnancy may also be associated with perinatal mortality, prematurity, smaller neonatal size and lower birth weight (Pierce et al., 2011; Mendez-Figueroa et al., 2011). Although primary influenza pneumonia is a rare complication that may occur at any age and carries a high case fatality rate (Barker and Mullooly, 1982), it was seen more frequently during the 2009 pandemic and the following influenza season. -
A Review on Swine Flu Infection and Strategies for Its Treatment in Future
Journal of Analytical & Pharmaceutical Research Review Article Open Access A review on swine flu infection and strategies for its treatment in future Abstract Volume 9 Issue 1 - 2020 H1N1 influenza infection is one of the most influential types of influenza viruses that enamored and surrenders almost all age gatherings of human populaces. This paper exhibits Prashant Kumar Dhakad, Mahaveer Singh School of Pharmaceutical Sciences, Jaipur National University, nitty-gritty data in regards to general mechanism of H1N1 infection, the impact of swine flu in people, correlation of swine flu infection with liquor utilization, common cold, and India noteworthiness of obesity. Pandemic spread in 2009, the pharmacological role of plant Correspondence: Prashant Kumar Dhakad PhD, Assistant supplements in context of H N and their uses and a metric study showing the ranking 1 1 Professor, School of Pharmaceutical Sciences, Jaipur National of supplements with the highest frequency of occurrence (F supplement) and ranking of University, Jagatpura, Jaipur, Rajasthan-302017, India, supplement with highest probabilities of co-occurrence with H1N1 (P supplement) has been Email portrayed in the present review. Received: November 22, 2019 | Published: January 24, 2020 Keywords: H1N1, influenza virus, swine flu, pandemic, f supplement, p supplement Introduction glycoprotein on the outside of upper respiratory tract or erythrocytes of host and chemical NA cuts sialic corrosive from cell surface and The present survey deals with information regarding the sufferings free relatives of infection from tainted patient cells. Swine influenza caused during the H1N1 infection happened in 2009, pathophysiology taints the respiratory tract of pigs, bringing about nasal discharges, a of swine influenza disease, genomic impact of swine influenza in yelping hack, diminished hunger, and drowsy conduct. -
ISSN 1661-8211 | 119. Jahrgang | 15. Dezember 2019
2019/23 ISSN 1661-8211 | 119. Jahrgang | 15. Dezember 2019 Redaktion und Herausgeberin: Schweizerische Nationalbibliothek NB, Hallwylstrasse 15, CH-3003 Bern Erscheinungsweise: halbmonatlich, am 15. und 30. jeden Monats Hinweise unter: http://ead.nb.admin.ch/web/sb-pdf/ ISSN 1661-8211 © Schweizerische Nationalbibliothek NB, CH-3003 Bern. Alle Rechte vorbehalten Inhaltsverzeichnis - Table des matières - Sommario - Cuntegn - Table of contents Inhaltsverzeichnis - Table des matières - 300 Sozialwissenschaften / Sciences sociales / Scienze Sommario - Cuntegn - Table of contents sociali / Scienzas socialas / Social sciences.......................... 12 000 Allgemeine Werke, Informatik, 300 Sozialwissenschaften, Soziologie / Sciences sociales, Informationswissenschaft / Informatique, information, sociologie / Scienze sociali, sociologia / Scienzas socialas, ouvrages de référence / Informatica, scienza sociologia / Social sciences, sociology.........................................12 dell'informazione, generalità / Informatica, infurmaziun e referenzas generalas / Computers, information and general 310 Allgemeine Statistiken / Statistiques générales / Raccolte di statistiche generali / Statistica generala / Collections of general reference........................................................................................ 1 statistics......................................................................................... 14 320 Politikwissenschaft / Science politique / Scienza politica / 000 Allgemeine Werke, Wissen, Systeme / Généralités, -
Explorations | Exploraciones
European Review of Latin American and Caribbean Studies Revista Europea de Estudios Latinoamericanos y del Caribe No. 109 (2020): January-June, pp. 203-211 www.erlacs.org Explorations | Exploraciones Repressed memory: Rethinking the impact of Latin America’s forgotten pandemics Bert Hoffmann German Institute of Global and Area Studies (GIGA) Abstract The ‘Columbian exchange’ (Crosby) after 1492 mixed bacteria and viruses from the ‘Old’ and the ‘New World’; ever since then, epidemics have shaped the political course of events in Latin America and the Caribbean. While the diseases and their victims are largely forgot- ten in collective memory, they also remain marginal in much of conventional scholarship, as they are not easily framed in narratives of national history or social emancipation. The pre- sent contribution provides concrete examples that demonstrate the profound political impact of pandemics, but also the lack of attention they have received in standard textbooks and accounts of Latin American history. The conclusions call on scholars to fully embrace the insights from environmental history and epidemiological research into their teaching and writing on the region. Keywords: Public Health, epidemics, environmental history, ecology, yellow fever, covid-19, Cuba. Resumen: Memoria reprimida: Reflexión sobre el impacto de las pandemias olvidadas de Latinoamérica El ‘intercambio colombino’ (Crosby) después de 1492 mezcló bacterias y virus del Viejo y el Nuevo Mundo. Desde entonces, las epidemias han moldeado el curso político de los acon- tecimientos en Latinoamérica y el Caribe. Si bien las enfermedades y sus víctimas caen en el olvido en gran medida en la memoria colectiva, también permanecen marginales en gran parte de la literatura académica convencional, ya que no se enmarcan fácilmente en narrati- vas de historia nacional o de emancipación social. -
Flu Season Which Can Last As Late As May
What Everyone Should Know About Seasonal Flu and the Seasonal Flu Vaccine Seasonal flu is not just a really bad cold. The flu is a contagious illness that affects the nose, throat, lungs and other parts of the body. It can spread quickly from one person to another. It can cause mild to severe illness, and at times can lead to death. Flu viruses are spread mainly from person to person through coughing or sneezing by people with influenza. Sometimes people may become infected by touching something - such as a surface or object - with flu viruses on it and then touching their mouth or nose. Every year in the U.S., on average: • 5% to 20% of the population gets the flu, • More than 200,000 people are hospitalized from seasonal flu complications and; • About 23,500 (and as high as about 48,000) people die from seasonal flu. The best way to prevent seasonal flu is by getting a flu shot or flu spray vaccination every year. When to get vaccinated against seasonal flu: Yearly flu vaccination should begin in September, or as soon as vaccine is available, and continue throughout the flu season which can last as late as May. This is because the timing and duration of flu seasons vary. While flu season can begin early as October, most of the time seasonal flu activity peaks in January, February or later. http://www.cdc.gov/flu/keyfacts.htm You can't get flu from getting a flu vaccine! The flu vaccine does not give you the flu. -
Antiviral Drugs for Influenza Prevention and Treatment
Antiviral Drugs for Influenza Prevention and Treatment Antiviral drugs are not a substitute for influenza (flu) vaccination. However, prescription antiviral medications play an important role in preventing and controlling the spread of influenza. These medications are a critical component of the U.S. Centers for Disease Control and Prevention (CDC) “Take 3” Actions to Fight the Flu. Take 3 urges everyone age 6 months and older to get vaccinated, follow good hand hygiene and cough/sneeze etiquette, and to take antiviral medications if they are prescribed.1 Influenza antiviral drugs are available to treat and prevent influenza: For Treatment: Antiviral drugs can reduce influenza symptoms, shorten the duration of illness, and prevent serious complications, like pneumonia, if taken within 48 hours of symptom onset.1,2 For Prevention: Antiviral drugs may also be prescribed to help prevent influenza in individuals who have been exposed to the virus. Antiviral drugs are about 70 to 90 percent effective when used as directed for prevention.3 For the 2014-15 flu season, CDC recommends use of either oseltamivir (Tamiflu®) or zanamivir (Relenza®) for treatment and prevention of influenza.2 Oseltamivir and zanamivir are dosed and administered differently, and are recommended for patients based on age and risk factors. A healthcare professional is best equipped to make an appropriate flu diagnosis and determine if antiviral treatment is recommended. More information about antiviral treatments is available at http://www.cdc.gov/flu/antivirals. Time Is of the Essence With antiviral therapy, timing is critical. A healthcare professional should be contacted at the first sign of influenza symptoms such as sudden onset of fever, aches, chills, and tiredness (for more information, see the fact sheet “Understanding Influenza”). -
Joining Forces in Influenza Pandemic Preparedness
Joining forces in influenza pandemic preparedness INFLUENZA PREPAREDNESS STAKEHOLDER CONFERENCE ON THE CENTENARY OF THE 1918 INFLUENZA PANDEMIC 22 JANUARY 2019, CHATHAM HOUSE, LONDON, UK MEETING REPORT 1918 FLU PANDEMIC WE REMEMBER. WE PREPARE. Click here, to see all lectures and a summary of the stakeholder debate. 2 JOINING FORCES IN INFLUENZA PANDEMIC PREPAREDNESS Table of contents About the organizers ........................................................................................................................................................................................................................................................4 How devastating was the 1918 pandemic and why? .......................................................................................................................................................9 Mrs Laura Spinney, Writer and science journalist, France The threat of a new influenza pandemic: its certainty, its unpredictability (or not?), its potential magnitude and speed ............................................................................................................................................................................................................10 Dr Gülsah Gabriel, Heinrich Pette Institute, Germany Virus evolution studies using ancient sequences ....................................................................................................................................................................12 Dr Terry Jones, University of Cambridge, UK Coping -
Twitter Influence on UK Vaccination and Antiviral Uptake During the 2009 H1N1 Pandemic
Twitter influence on UK vaccination and antiviral uptake during the 2009 H1N1 pandemic Article (Published Version) McNeill, Andrew, Harris, Peter and Briggs, Pam (2016) Twitter influence on UK vaccination and antiviral uptake during the 2009 H1N1 pandemic. Frontiers in Public Health, 4. ISSN 2296-2565 This version is available from Sussex Research Online: http://sro.sussex.ac.uk/id/eprint/61335/ This document is made available in accordance with publisher policies and may differ from the published version or from the version of record. If you wish to cite this item you are advised to consult the publisher’s version. Please see the URL above for details on accessing the published version. Copyright and reuse: Sussex Research Online is a digital repository of the research output of the University. Copyright and all moral rights to the version of the paper presented here belong to the individual author(s) and/or other copyright owners. To the extent reasonable and practicable, the material made available in SRO has been checked for eligibility before being made available. Copies of full text items generally can be reproduced, displayed or performed and given to third parties in any format or medium for personal research or study, educational, or not-for-profit purposes without prior permission or charge, provided that the authors, title and full bibliographic details are credited, a hyperlink and/or URL is given for the original metadata page and the content is not changed in any way. http://sro.sussex.ac.uk ORIGINAL RESEARCH published: 22 February 2016 doi: 10.3389/fpubh.2016.00026 Twitter influence on UK Vaccination and Antiviral Uptake during the 2009 H1N1 Pandemic Andrew McNeill1 , Peter R.